Advanced search
1 file | 1.59 MB Add to list

2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation

Jeroen Verhoeven (UGent) , Tristan Baguet (UGent) , Sarah Piron (UGent) , Glenn Pauwelyn (UGent) , Charlotte Bouckaert (UGent) , Benedicte Descamps (UGent) , Robrecht Raedt (UGent) , Christian Vanhove (UGent) , Filip De Vos (UGent) and Ingeborg Goethals (UGent)
Author
Organization
Keywords
Molecular Medicine, Cancer Research, Radiology Nuclear Medicine and imaging, RECURRENT BRAIN-TUMOR, O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET, F-18-FDG PET, DIFFERENTIATING RECURRENT, C-11-METHIONINE PET, FDG, SENSITIVITY, GLIOMA, TOMOGRAPHY, DIAGNOSIS

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.59 MB

Citation

Please use this url to cite or link to this publication:

MLA
Verhoeven, Jeroen, et al. “2-[18F]FELP, a Novel LAT1-Specific PET Tracer, for the Discrimination between Glioblastoma, Radiation Necrosis and Inflammation.” NUCLEAR MEDICINE AND BIOLOGY, vol. 82–83, 2020, pp. 9–16, doi:10.1016/j.nucmedbio.2019.12.002.
APA
Verhoeven, J., Baguet, T., Piron, S., Pauwelyn, G., Bouckaert, C., Descamps, B., … Goethals, I. (2020). 2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation. NUCLEAR MEDICINE AND BIOLOGY, 8283, 9–16. https://doi.org/10.1016/j.nucmedbio.2019.12.002
Chicago author-date
Verhoeven, Jeroen, Tristan Baguet, Sarah Piron, Glenn Pauwelyn, Charlotte Bouckaert, Benedicte Descamps, Robrecht Raedt, Christian Vanhove, Filip De Vos, and Ingeborg Goethals. 2020. “2-[18F]FELP, a Novel LAT1-Specific PET Tracer, for the Discrimination between Glioblastoma, Radiation Necrosis and Inflammation.” NUCLEAR MEDICINE AND BIOLOGY 82–83: 9–16. https://doi.org/10.1016/j.nucmedbio.2019.12.002.
Chicago author-date (all authors)
Verhoeven, Jeroen, Tristan Baguet, Sarah Piron, Glenn Pauwelyn, Charlotte Bouckaert, Benedicte Descamps, Robrecht Raedt, Christian Vanhove, Filip De Vos, and Ingeborg Goethals. 2020. “2-[18F]FELP, a Novel LAT1-Specific PET Tracer, for the Discrimination between Glioblastoma, Radiation Necrosis and Inflammation.” NUCLEAR MEDICINE AND BIOLOGY 82–83: 9–16. doi:10.1016/j.nucmedbio.2019.12.002.
Vancouver
1.
Verhoeven J, Baguet T, Piron S, Pauwelyn G, Bouckaert C, Descamps B, et al. 2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation. NUCLEAR MEDICINE AND BIOLOGY. 2020;82–83:9–16.
IEEE
[1]
J. Verhoeven et al., “2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation,” NUCLEAR MEDICINE AND BIOLOGY, vol. 82–83, pp. 9–16, 2020.
@article{8639046,
  author       = {Verhoeven, Jeroen and Baguet, Tristan and Piron, Sarah and Pauwelyn, Glenn and Bouckaert, Charlotte and Descamps, Benedicte and Raedt, Robrecht and Vanhove, Christian and De Vos, Filip and Goethals, Ingeborg},
  issn         = {0969-8051},
  journal      = {NUCLEAR MEDICINE AND BIOLOGY},
  keywords     = {Molecular Medicine,Cancer Research,Radiology Nuclear Medicine and imaging,RECURRENT BRAIN-TUMOR,O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET,F-18-FDG PET,DIFFERENTIATING RECURRENT,C-11-METHIONINE PET,FDG,SENSITIVITY,GLIOMA,TOMOGRAPHY,DIAGNOSIS},
  language     = {eng},
  pages        = {9--16},
  title        = {2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation},
  url          = {http://dx.doi.org/10.1016/j.nucmedbio.2019.12.002},
  volume       = {82-83},
  year         = {2020},
}

Altmetric
View in Altmetric
Web of Science
Times cited: